Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Top Cited Papers
Open Access
- 26 March 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Analysis
- Vol. 10 (4), 313-319
- https://doi.org/10.1016/j.jpha.2020.03.009
Abstract
No abstract availableKeywords
Funding Information
- Hubei Provincial Natural Science Foundation (2019CFA014)
- Guangxi University, Nanning, China
- Guangxi University, Nanning, China
This publication has 36 references indexed in Scilit:
- admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET PropertiesJournal of Chemical Information and Modeling, 2012
- NCBI BLAST: a better web interfaceNucleic Acids Research, 2008
- BLAST: improvements for better sequence analysisNucleic Acids Research, 2006
- Isoflavonoids and Other Compounds from Psorothamnus arborescens with Antiprotozoal ActivitiesJournal of Natural Products, 2005
- Design and Synthesis of Peptidomimetic Severe Acute Respiratory Syndrome Chymotrypsin-like Protease InhibitorsJournal of Medicinal Chemistry, 2005
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- T-coffee: a novel method for fast and accurate multiple sequence alignmentJournal of Molecular Biology, 2000
- ESPript: analysis of multiple sequence alignments in PostScript.Bioinformatics, 1999
- GROMACS: A message-passing parallel molecular dynamics implementationComputer Physics Communications, 1995